HDAC inhibitor Belinostat, Purity ≥98%

Cat. No.: X23-10-ZQ258

HDAC inhibitor Belinostat, Purity ≥98%

Synonym: 414864-00-9; 866323-14-0; Belinostat; PXD101; Belinostat (PXD101); Beleodaq; PXD-101; (E)-N-Hydroxy-3-(3-(N-phenylsulfamoyl)phenyl)acrylamide; HDAC inhibitor

  • MDL: MFCD08064035
  • CAS Number: 414864-00-9
  • Compound CID: 6918638
Product Size
10 mg; 25 mg; 50 mg; 100 mg; 200 mg
Price
Datasheet
MSDS
Properties
Description
Belinostat, soluble in DMSO and insoluble in ethanol and water, induces DNA damage and the inhibition of DNA repair processes. It targets HDAC.
Molecular Weight
318.4
Molecular Formula
C15H14N2O4S
Targets
HDAC: 27 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 56 mg/mL (175.9 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
Belinostat can be used to investigate its inhibitory effects on HDAC enzymes in cancer treatment.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.